Testing effectiveness (Phase 2)Study completedNCT03546621
What this trial is testing
A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D
Who this might be right for
Chronic Hepatitis D Infection With Hepatitis B
Hepatera Ltd. 120